Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 84 matches for

Africa’s change-makers: meet the Mastercard Foundation Scholars with big ambitions for the future

By 2050, Africa will host a majority of the world's student-age population, shaping global futures. The Mastercard Foundation Scholars at Oxford's Africa Oxford Initiative receive full scholarships, rigorous education, leadership training, entrepreneurship support and networking, preparing them to lead Africa's and the world's future challenges and opportunities.

Myanmar-Thailand: Healthcare access without barriers

In Myanmar, the United Nations reports that 3 million people have been displaced due to the ongoing civil war. The 2021 coup intensified conflicts and worsened the humanitarian crisis, forcing at least a hundred thousand to seek refuge and medical care in Thailand.

Professor Sassy Molyneux awarded five-year NIHR Global Health Research Professorship

Professor Sassy Molyneux has received a prestigious five-year NIHR Global Health Research Professorship to study how to better protect frontline staff in international health research from moral distress. This is one of only five to seven such `flagship’ professorships awarded by the NIHR each year to outstanding scientists.

Shorter life expectancy during COVID-19 for India’s marginalised

A new paper published in Science Advances finds that life expectancy in India was 2.6 years lower in 2020 than 2019, with women and marginalised social groups suffering the greatest declines.

Côte d’Ivoire makes history as first nation to deploy R21/Matrix-M™ Malaria Vaccine

Today marks the official rollout of the new R21/Matrix-M™ malaria vaccine - co-developed by the University of Oxford and Serum Institute of India, leveraging Novavax’s Matrix-M™ adjuvant technology. In a historic step in the battle to beat malaria, the first official vaccination is due to take place in Abidjan, Côte d’Ivoire, this morning and will be subsequently rolled-out in 38 districts across the country.

Shipment of R21 malaria vaccine to Central African Republic marks latest milestone for child survival

Last month, UNICEF delivered over 43,200 doses of the R21/Matrix-M malaria vaccine developed through collaboration between Oxford University’s Jenner Institute and Serum Institute of India leveraging by Novavax’s saponin-based adjuvant technology, by air to Bangui, Central African Republic, with further shipment of about 163,800 doses to follow, which is allocated for children in the CAR currently.

Forecasting how best to control and eliminate Neglected Tropical Diseases

Neglected tropical diseases (NTDs) are a major cause of death, disability, and economic hardship worldwide, particularly in low- and middle-income countries. While many of these diseases are targeted for control, elimination, or eradication by 2030, achieving those targets will be challenging due to disruptions to programmes related to the COVID-19 pandemic and differences in disease transmission across regions, which requires tailoring interventions to local settings.

Placing community health workers in remote areas key to eliminating Falciparum malaria in Myanmar and GMS

Medical Action Myanmar successfully eliminated falciparum malaria in Eastern Myanmar within six years, employing 172 community health workers for early diagnosis and treatment. Their approach, integrating basic health services with malaria care, led to a rapid reduction in both falciparum and vivax malaria cases. This cost-effective strategy challenges traditional, labour-intensive methods, emphasizing the importance of community health workers in achieving malaria elimination in challenging, remote areas.

Developing new antibiotics to safeguard modern medicine

The increasing use of antibiotics globally and has exacerbated the evolution of multidrug-resistant bacteria which can no longer be treated by many antibiotics which were previously effective. This causes multi-drug resistant infections in both humans and animals that are no longer easily treatable and can lead to death.

Understanding antimicrobial resistance to implement change

Robust and strong surveillance systems across the world, especially in low-and middle-income countries are essential to tackle Anti-Microbial Resistance (AMR). At the national level, data can help inform health policies and responses to health emergencies. At the global level, this data can provide early warnings of emerging threats and help identify long–term trends.

The Big Shot - Oxford, Africa and the R21 malaria vaccine

"What we desperately need are new tools to improve malaria control, and this is the first vaccine that can be deployed at scale, that will be affordable, and can be used widely in Africa on a scale of hundreds of millions of doses each year" - Professor Adrian Hill

Cooling the world without heating the planet

Cooling is necessary for the health and quality of life of billions of people around the world. Extreme heat increases the risk of heart attacks, strokes and other cardiovascular diseases, exacerbates chronic conditions, and can lead to dehydration, heat exhaustion, and even death, especially in vulnerable populations - it is estimated that there were over 60,000 heat-related deaths in Europe in 2022.

Vaccines: From lab to licensing

The standard for testing and monitoring of vaccines is higher than it is for most other medicines because they are one of the few medical treatments given to healthy people - mainly healthy children. This means that the level of acceptable risk is much lower than it might be in some other treatments. It can take many years for a vaccine to pass through all the stages described in the animation. In the case of the MenB vaccine, for example, it took 15 years from the first publication of the genome (the complete set of genetic information in an organism) to the vaccine being licensed for use.

Infecting Minds: The Past, Present and Future of Vaccine Hesitancy

Infecting Minds: The Past, Present and Future of Vaccine Hesitancy is an interdisciplinary project exploring vaccine hesitancy in South Africa and the UK. We are interested in understanding barriers to vaccination, and learning how beliefs and behaviours around vaccines develop, persist, and spread in different settings. We explore these using perspectives from social sciences, theology, history, and community engagement. This film documents our research as well as our engagement work with schools in Durban, Somkhele, and Oxford over 2022 and 2023.

Fight against drug-resistant malaria in critical new phase: 'We are in danger of losing our current antimalarial drugs to resistance.'

On World Malaria Day 2023, the global fight against malaria has hit a critical point in Africa. Recent studies have confirmed that malaria parasites resistant to artemisinin have emerged in Rwanda, Uganda and the Horn of Africa. Artemisinin-based combination therapies (ACTs) are the first line treatment for malaria and there is no immediate replacement available. The loss of ACTs will put millions of Africans, mostly children under the age of 5, at risk of drug-resistant malaria infection and death.

A test to combat antimicrobial resistance

When you’re sick all you want to do is feel better as soon as possible. A team of researchers are developing a new test for bacterial infections to make that possible, while also contributing to more effective antibiotic stewardship – a key component of global efforts to combat the dangerous rise of antibiotic-resistant infections.

Can you make a dengue fever forecast?

More than half the world’s population is at risk from dengue fever, a viral infection that is spread via the bite of an infected mosquito. While some cases of the disease can be mild, others can be extremely dangerous and even fatal – particularly if someone has contracted the virus previously. When cases of dengue fever are high, those at risk can take some preventative measures, such as wearing clothing that covers as much skin as possible, using mosquito nets at night, and avoiding standing water. As such, some way of predicting high levels of the virus before they arrive would be invaluable. This is exactly what Dr Sarah Sparrow and her colleagues at the DART (Dengue Advanced Readiness Tools) project are hoping to achieve – using climate data to create a forecast, similar to a pollen forecast, for dengue fever.

Science with Sanjula: Professor Patricia Kingori

Inclusion and global health decision-making

Science with Sanjula: Professor Sir Peter Horby

Saving over a million lives

Science with Sanjula: Professor Ngaire Woods

Building trust to improve global health

Load More